Regulatory News

Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Collaboration to Improve Viral Vector Industrialisation ProcessCollaboration to Improve Viral Vector Industrialisation ProcessCell Therapy Catapult Awards Major Contract to Cellular Therapeutics Limited to Accelerate WT1 Clinical ProgrammeCell Therapy Catapult Awards Major Contract to Cellular Therapeutics Limited to Accelerate WT1 Clinical ProgrammeCAT publishes Monthly Report for July 2015CAT publishes Monthly Report for July 2015EMA publishes new draft guidance on fast track routes to marketing authorisationEMA publishes new draft guidance on fast track routes to marketing authorisationEMA announces workshop on facilitating the development of advanced therapies in September 2015EMA announces workshop on facilitating the development of advanced therapies in September 2015Early dialogue to support development of medicines for childrenEarly dialogue to support development of medicines for childrenFDA issue draft guidance on developing drugs for Duchenne Muscular DystrophyFDA issue draft guidance on developing drugs for Duchenne Muscular DystrophyFDA issues final guidance on early phase clinical trials for gene and cell therapiesFDA issues final guidance on early phase clinical trials for gene and cell therapiesEMA adopts Reflection Paper on Classification of ATMPsEMA adopts Reflection Paper on Classification of ATMPsCell Therapy Catapult and Asymptote Collaborate to Revolutionise Delivery of Cell TherapiesCell Therapy Catapult and Asymptote Collaborate to Revolutionise Delivery of Cell TherapiesTxCell and Trizell amend collaboration agreement to accelerate Ovasave developmentTxCell and Trizell amend collaboration agreement to accelerate Ovasave developmentCell Medica Collaborates with Cell Therapy Catapult to Help Bring Its New Treatment to NHSCell Medica Collaborates with Cell Therapy Catapult to Help Bring Its New Treatment to NHS